RIL
ALNY icon

Rothschild Investment LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History

Rothschild Investment LLC’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$831K Buy
2,761
+2,602
+1,636% +$785K 0.03% 460
2026
Q1 		$52.6K Sell
159
-201
-56% -$68.4K ﹤0.01% 1097
2025
Q4 		$143K Sell
360
-718
-67% -$318K 0.01% 721
2025
Q3 		$492K Buy
1,078
+1,076
+53,800% +$438K 0.03% 356
2025
Q2 		$652 Sell
2
-1
-33% -$277 ﹤0.01% 2649
2025
Q1 		$810 Buy
3
+2
+200% +$514 ﹤0.01% 2451
2024
Q4 		$235 Buy
+1
New +$263 ﹤0.01% 2756

Other funds holding ALNY

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Rothschild Investment LLC's ALNY Position: Q2 2026 in Review

Rothschild Investment LLC increased its Alnylam Pharmaceuticals (ALNY) stake by 1,636% in Q2 2026, buying an estimated $785K and bringing the position to 2,761 shares worth $831K. The position accounts for 0.03% of the portfolio, ranked #460.

Rothschild Investment LLC first reported a position in ALNY in Q4 2024 and has held it in 7 quarters since. 330 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Rothschild Investment LLC held 2,761 shares of Alnylam Pharmaceuticals worth $831K as of Q2 2026.
  • Rothschild Investment LLC bought 2,602 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $785K.
  • Alnylam Pharmaceuticals made up 0.03% of Rothschild Investment LLC's portfolio in Q2 2026, its #460 holding.
  • Rothschild Investment LLC first reported a position in Alnylam Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 330 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.